Definium Therapeutics, Inc. (DFTX) at a glance

Definium Therapeutics, Inc. (DFTX) is a mid-cap Healthcare company. It trades at $38.5, with a 0% profit margin. It does not pay a dividend. Vestovix scores it 40/100 overall. Its strongest dimension is Momentum (67/100) and its weakest is Safety (12/100). It carries above-market volatility, so expect larger swings.

Price

$38.50

Market cap

$2.70B

P/E ratio

n/a

Dividend yield

None

Beta

2.38

52-week range

$8.70 to $49.70